Q1 2025 · 13F-HR
Rosalind Advisors, Inc.holdings as filed
Filed 2025-05-14 · accession 0001622627-25-000027
$205.6M
Reported value
34
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 24661P807 | DCTH | DELCATH SYS INC | $29.0M | 14.1% | 2,900,389 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $15.9M | 7.75% | 2,644,517 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $13.7M | 6.66% | 2,495,986 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $13.0M | 6.32% | 2,703,661 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $11.5M | 5.58% | 700,000 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $10.9M | 5.28% | 1,782,844 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $10.5M | 5.11% | 950,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $8.9M | 4.34% | 1,218,700 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $8.6M | 4.18% | 1,805,817 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $8.3M | 4.03% | 850,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $8.0M | 3.90% | 595,000 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $7.9M | 3.83% | 506,893 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $7.4M | 3.58% | 2,654,944 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $6.3M | 3.09% | 100,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $6.1M | 2.98% | 2,274,990 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $5.1M | 2.50% | 810,918 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $4.3M | 2.10% | 2,451,500 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MED CORP | $4.0M | 1.96% | 692,185 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $3.9M | 1.87% | 612,901 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $3.5M | 1.71% | 223,627 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $3.5M | 1.71% | 303,864 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $2.8M | 1.34% | 1,018,021 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $2.5M | 1.19% | 420,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.4M | 1.15% | 823,286 | Common | SOLE |
| 68404V209 | OPTNUSD | OPTINOSE INC | $2.3M | 1.14% | 256,190 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $1.5M | 0.72% | 248,285 | Common | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $991,950 | 0.48% | 2,003,939 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $752,678 | 0.37% | 250,059 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $660,000 | 0.32% | 100,000 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $530,470 | 0.26% | 104,836 | Common | SOLE |
| 09077D209 | BFRI | BIOFRONTERA INC | $515,514 | 0.25% | 644,393 | Common | SOLE |
| 46090E953 | — | INVESCO QQQ TR | $373,500 | 0.18% | 50,000 | PUT | SOLE |
| 528872902 | — | LEXICON PHARMACEUTICALS INC | $30,000 | 0.01% | 1,278,900 | CALL | SOLE |
| 137404959 | — | CANDEL THERAPEUTICS INC | $3,570 | 0.00% | 15,800 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.